Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Avantor, Inc. (NYSE: AVTR), a global leader in providing important products and services to life sciences and advanced technology industries, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event will take place in New York on September 5, 2024.
Michael Stubblefield, President and CEO of Avantor, will engage in a fireside chat at approximately 10:45 a.m. Eastern Daylight Time. Interested parties can access a live audio webcast of the session through the Events & Presentations section of Avantor's investor relations website. The webcast replay will remain available for 30 days following the event.
Avantor, Inc. (NYSE: AVTR), un leader globale nella fornitura di prodotti e servizi essenziali per i settori delle scienze della vita e delle tecnologie avanzate, ha annunciato la sua partecipazione alla 22ª Conferenza Globale sulla Salute di Morgan Stanley. L'evento si svolgerà a New York il 5 settembre 2024.
Michael Stubblefield, Presidente e CEO di Avantor, parteciperà a una chiacchierata informale intorno alle 10:45 AM Eastern Daylight Time. Le parti interessate possono accedere a una trasmissione audio in diretta della sessione attraverso la sezione Eventi e Presentazioni del sito web delle relazioni con gli investitori di Avantor. La registrazione della trasmissione rimarrà disponibile per 30 giorni dopo l'evento.
Avantor, Inc. (NYSE: AVTR), un líder global en el suministro de productos y servicios importantes para las industrias de ciencias de la vida y tecnología avanzada, ha anunciado su participación en la 22ª Conferencia Global de Salud de Morgan Stanley. El evento se llevará a cabo en Nueva York el 5 de septiembre de 2024.
Michael Stubblefield, Presidente y CEO de Avantor, participará en una conversación informal aproximadamente a las 10:45 AM Hora de Verano del Este. Las partes interesadas pueden acceder a una transmisión de audio en vivo de la sesión a través de la sección de Eventos y Presentaciones en el sitio web de relaciones con inversores de Avantor. La repetición de la transmisión estará disponible durante 30 días después del evento.
Avantor, Inc. (NYSE: AVTR)는 생명 과학 및 첨단 기술 산업에 중요한 제품 및 서비스를 제공하는 글로벌 리더로서, 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 5일 뉴욕에서 개최됩니다.
Avantor의 회장 겸 CEO인 Michael Stubblefield는 약 동부 일광 절약 시간 기준으로 오전 10:45에 대화에 참여합니다. 관심 있는 분들은 Avantor 투자자 관계 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 세션의 실시간 오디오 웹캐스트에 접속할 수 있습니다. 웹캐스트 다시 보기 기능은 행사 후 30일 동안 제공됩니다.
Avantor, Inc. (NYSE: AVTR), un leader mondial dans la fourniture de produits et services essentiels aux secteurs des sciences de la vie et des technologies avancées, a annoncé sa participation à la 22ème Conférence Mondiale sur la Santé de Morgan Stanley. L'événement aura lieu à New York le 5 septembre 2024.
Michael Stubblefield, Président et CEO d'Avantor, prendra part à une discussion informelle vers 10h45, heure avancée de l'Est. Les parties intéressées peuvent accéder à un webinaire audio en direct de la session via la section Événements & Présentations du site web des relations investisseurs d'Avantor. La rediffusion du webinaire sera disponible pendant 30 jours suivant l'événement.
Avantor, Inc. (NYSE: AVTR), ein globaler Marktführer in der Bereitstellung wichtiger Produkte und Dienstleistungen für die Lebenswissenschaften und die fortschrittlichen Technologiebranchen, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt gegeben. Die Veranstaltung findet am 5. September 2024 in New York statt.
Michael Stubblefield, Präsident und CEO von Avantor, wird gegen 10:45 Uhr Eastern Daylight Time an einem informellen Austausch teilnehmen. Interessierte können über den Bereich Veranstaltungen & Präsentationen auf der Investor-Relations-Website von Avantor auf einen Live-Audio-Webcast der Sitzung zugreifen. Die Wiederholung des Webcasts bleibt 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
View original content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227701.html
SOURCE Avantor and Financial News
FAQ
When is Avantor (AVTR) participating in the Morgan Stanley Global Healthcare Conference?
Who will represent Avantor (AVTR) at the Morgan Stanley Healthcare Conference?
What time is Avantor's (AVTR) fireside chat at the Morgan Stanley conference?
How can investors listen to Avantor's (AVTR) presentation at the Morgan Stanley conference?
How long will the replay of Avantor's (AVTR) Morgan Stanley conference webcast be available?
